• Department of Cardiac and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, P. R. China;
CHENG Cai, Email: Cai.cheng@hotmail.com
Export PDF Favorites Scan Get Citation

Objective To report our clinical experience and outcomes of thoracic endovascular aortic repair (TEVAR) for acute Stanford type A dissection using ascending aorta replacement combined with implantation of a fenestrated stent-graft of the entire aortic arch through a minimally invasive technique. Methods From 2016 to 2020 in our hospital, 24 patients (17 males and 7 females, aged 45-72 years) with complicated Stanford type A aortic dissection, underwent replacement of the proximal ascending aorta with TEVAR. None of the patients with dissection involved the three branches of the superior arch, and all patients were replaced with artificial blood vessels of the ascending aorta under non-hypothermic cardiopulmonary bypass, preserving the arch and the three branches above the arch, and individualized stent graft fenestration. Results Surgical technical success rate was 100.0%. There was no intraoperative complication or evidence of endo-leak in 1 month postoperatively. Hospital stay was 10±5 d. During postoperative follow-up, the stent was unobstructed without displacement, the preserved branch of the aortic arch was unobstructed, and the true lumen of the descending aorta was enlarged. Conclusion  This hybrid technique by using TEVAR with fenestrated treatment is a minimally invasive and effective method to treat high-risk patients with acute Stanford type A aortic dissection.

Citation: MA Xiantao, ZHU Zhangqiang, FENG Yi, LI Shiliang, Wajeehullahi Akilu, WEI Xiang, CHENG Cai. Short-term outcome of ascending aorta replacement combined with total aortic arch fenestration technique for acute type A aortic dissection. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2022, 29(5): 577-584. doi: 10.7507/1007-4848.202111022 Copy

  • Previous Article

    A new surgical strategy for preventing large-for-size syndrome after DCD liver transplantation in adults
  • Next Article

    Progress and prospects: regulated cell death in cancer